Craig Wong-Pan
Stock Analyst at RBC Capital
(1.02)
# 3,915
Out of 5,081 analysts
344
Total ratings
48.6%
Success rate
-1.4%
Average return
Main Sectors:
Stocks Rated by Craig Wong-Pan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: HLS Healius Limited | Reiterated: Hold | $0.42 → $0.46 | $0.44 | +4.55% | 34 | Oct 22, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $21.00 | $12.85 | +63.42% | 11 | Oct 21, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $213.00 → $215.00 | $195.14 | +10.18% | 36 | Oct 6, 2026 | |
| ASX: ACL Australian Clinical Labs Limited | Reiterated: Hold | $2.40 | $2.98 | -19.46% | 22 | Sep 15, 2026 | |
| ASX: ANN Ansell Limited | Downgraded: Hold | $36.00 → $38.00 | $46.50 | -18.28% | 9 | Sep 15, 2026 | |
| ASX: COH Cochlear Limited | Reiterated: Hold | $117.00 | $141.82 | -17.50% | 23 | Sep 15, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.20 | $2.09 | +53.11% | 25 | Sep 15, 2026 | |
| ASX: NAN Nanosonics Limited | Upgraded: Buy | $3.00 → $3.75 | $3.10 | +20.97% | 20 | Sep 15, 2026 | |
| ASX: REG Regis Healthcare Limited | Reiterated: Hold | $5.00 | $4.76 | +5.04% | 30 | Sep 15, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Upgraded: Buy | $52.00 → $68.00 | $54.94 | +23.77% | 24 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21.00 | $19.09 | +10.01% | 27 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $39.00 → $52.00 | $48.38 | +7.48% | 6 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $244 → $262 | $253.20 | +3.48% | 38 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $82 | $110.90 | -25.82% | 1 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.75 → $0.72 | $0.71 | +1.41% | 13 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.12 → $0.13 | $0.10 | +30.00% | 22 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $16.04 | $24.65 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31.60 | $13.51 | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6.57 | $19.99 | n/a | 1 | May 22, 2019 |
Healius Limited
Oct 22, 2026
Reiterated: Hold
Price Target: $0.42 → $0.46
Current: $0.44
Upside: +4.55%
Telix Pharmaceuticals Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $21.00
Current: $12.85
Upside: +63.42%
CSL Limited
Oct 6, 2026
Reiterated: Buy
Price Target: $213.00 → $215.00
Current: $195.14
Upside: +10.18%
Australian Clinical Labs Limited
Sep 15, 2026
Reiterated: Hold
Price Target: $2.40
Current: $2.98
Upside: -19.46%
Ansell Limited
Sep 15, 2026
Downgraded: Hold
Price Target: $36.00 → $38.00
Current: $46.50
Upside: -18.28%
Cochlear Limited
Sep 15, 2026
Reiterated: Hold
Price Target: $117.00
Current: $141.82
Upside: -17.50%
Integral Diagnostics Limited
Sep 15, 2026
Reiterated: Buy
Price Target: $3.20
Current: $2.09
Upside: +53.11%
Nanosonics Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $3.00 → $3.75
Current: $3.10
Upside: +20.97%
Regis Healthcare Limited
Sep 15, 2026
Reiterated: Hold
Price Target: $5.00
Current: $4.76
Upside: +5.04%
Ramsay Health Care Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $52.00 → $68.00
Current: $54.94
Upside: +23.77%
Sep 15, 2026
Reiterated: Hold
Price Target: $21.00
Current: $19.09
Upside: +10.01%
Sep 15, 2026
Upgraded: Buy
Price Target: $39.00 → $52.00
Current: $48.38
Upside: +7.48%
Sep 15, 2026
Upgraded: Buy
Price Target: $244 → $262
Current: $253.20
Upside: +3.48%
Jul 16, 2026
Downgraded: Hold
Price Target: $82
Current: $110.90
Upside: -25.82%
Jun 11, 2026
Reiterated: Hold
Price Target: $0.75 → $0.72
Current: $0.71
Upside: +1.41%
May 18, 2026
Reiterated: Hold
Price Target: $0.12 → $0.13
Current: $0.10
Upside: +30.00%
Oct 6, 2020
Reiterated: Sell
Price Target: $16.04
Current: $24.65
Upside: n/a
Oct 6, 2020
Reiterated: Buy
Price Target: $31.60
Current: $13.51
Upside: n/a
May 22, 2019
Downgraded: Sell
Price Target: $6.57
Current: $19.99
Upside: n/a